Drugs in Development for TuberculosisGINSBERG, Ann M.Drugs (Basel). 2010, Vol 70, Num 17, pp 2201-2214, issn 0012-6667, 14 p.Article

What's new in tuberculosis vaccines?GINSBERG, Ann M.Bulletin of the World Health Organization. 2002, Vol 80, Num 6, pp 483-488, issn 0042-9686Article

Safety, Tolerability, and Pharmacokinetics of PA-824 in Healthy SubjectsGINSBERG, Ann M; LAURENZI, Martino W; ROUSE, Doris J et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 9, pp 3720-3725, issn 0066-4804, 6 p.Article

Randomized Dose-Ranging Study of the 14-Day Early Bactericidal Activity of Bedaquiline (TMC207) in Patients with Sputum Microscopy Smear-Positive Pulmonary TuberculosisDIACON, Andreas H; DAWSON, Rodney; WINTER, Helen et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 5, pp 2199-2203, issn 0066-4804, 5 p.Article

Early Bactericidal Activity and Pharmacokinetics of PA-824 in Smear-Positive Tuberculosis PatientsDIACON, Andreas H; DAWSON, Rodney; LAURENZI, Martino W et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 8, pp 3402-3407, issn 0066-4804, 6 p.Article

Phase II Dose-Ranging Trial of the Early Bactericidal Activity of PA-824DIACON, Andreas H; DAWSON, Rodney; SPIGELMAN, Melvin K et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 6, pp 3027-3031, issn 0066-4804, 5 p.Article

Assessment of the Effects of the Nitroimidazo-Oxazine PA-824 on Renal Function in Healthy SubjectsGINSBERG, Ann M; LAURENZI, Martino W; ROUSE, Doris J et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 9, pp 3726-3733, issn 0066-4804, 8 p.Article